Mitazalimab (ADC-1013) is a monoclonal IgG antibody targeting CD40 and a CD40 agonist with antitumor activity. Mitazalimab activates antigen-presenting cells, induces transient peripheral transcriptome changes, and can be used to study tumors.
Purity:
95.00%
CAS Number:
[2055640-86-1]
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted